CAMBRIDGE, Mass., Oct. 22 /PRNewswire-FirstCall/ -- Idenix Pharmaceuticals, Inc., announced today that it will report its financial results for the third quarter of 2009 on Thursday, October 29, 2009 after U.S. financial markets close.
In conjunction with the issuance of the press release, Idenix management will host a conference call at 4:30 p.m. ET on Thursday, October 29, 2009 to discuss the company’s financial results for the third quarter of 2009 and provide an update on the company’s discovery and development programs.
To access the call please dial 800-471-3635 U.S./Canada or 706-758-9475 International and enter passcode 37050246 or to listen to a live webcast and view accompanying slides, go to “Calendar of Events” in the Idenix Investor Center at www.idenix.com. A replay of the call will also be available from October 29, 2009, 6:30 p.m. ET until November 11, 2009, 11:59 p.m. ET. To access the replay, please dial 800-642-1687 U.S./Canada or 706-645-9291 International and enter passcode 37050246. An archived webcast will also be available for two weeks after the call on the Idenix website.
About Idenix
Idenix Pharmaceuticals, Inc., headquartered in Cambridge, Massachusetts, is a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human viral diseases. Idenix’s current focus is on the treatment of infections caused by the hepatitis C virus. For further information about Idenix, please refer to http://www.idenix.com.
SOURCE Idenix Pharmaceuticals, Inc.
CONTACT: Teri Dahlman of Idenix Pharmaceuticals, Inc., +1-617-995-9905
Web site: http://www.idenix.com/
